Technische Universität München (TUM)

Two dimensional and real-time three dimensional ultrasound measurements of left ventricular diastolic function after marathon running: results from a substudy of the BeMaGIC trial (2019) Roeh A, Schuster T, Jung P, Schneiders J, Halle M, Scherr J Journal article Hemostatic abnormalities in adult patients with marfan syndrome (2019) Kornhuber KT, Seidel H, Pujol C, Meierhofer C, Roeschenthaler F, Pressler A, Stoeckl A, et al. Journal article Controlling neural networks via energy dissipation (2019) Moeller M, Moellenhoff T, Cremers D Conference contribution Variational uncalibrated photometric stereo under general lighting (2019) Haefner B, Ye Z, Gao M, Wu T, Queau Y, Cremers D Conference contribution End of life: individual—together—interdisciplinary: Cooperation between radiotherapy and palliative medicine End of Life: Individuell – Gemeinsam – Interdisziplinär: Zusammenarbeit zwischen Strahlentherapie und Palliativmedizinischer Dienst (2019) Asadpour R, Pigorsch SU, Combs SE Journal article Factors associated with the decline of psychological support in hospitalized patients with cancer (2019) Pichler T, Dinkel A, Marten-Mittag B, Hermelink K, Telzerow E, Ackermann U, Belka C, et al. Journal article Tumor grading of soft tissue sarcomas using MRI-based radiomics (2019) Peeken JC, Spraker MB, Knebel C, Dapper H, Pfeiffer D, Devecka M, Thamer A, et al. Journal article Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922 (2019) Kuehnel A, Schilling D, Combs SE, Haller B, Schwab M, Multhoff G Journal article Social Support and Modelling in Relation to Physical Activity Participation and Outdoor Play in Preschool Children (2019) Reimers AK, Boxberger K, Schmidt SCE, Niessner C, Demetriou Y, Marzi I, Woll A Journal article, Original article Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations (2019) Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, et al. Conference contribution